IN2012DN02624A - - Google Patents

Download PDF

Info

Publication number
IN2012DN02624A
IN2012DN02624A IN2624DEN2012A IN2012DN02624A IN 2012DN02624 A IN2012DN02624 A IN 2012DN02624A IN 2624DEN2012 A IN2624DEN2012 A IN 2624DEN2012A IN 2012DN02624 A IN2012DN02624 A IN 2012DN02624A
Authority
IN
India
Prior art keywords
animals
day
amounts
preventing
comprise administering
Prior art date
Application number
Other languages
English (en)
Inventor
Yuanlong Pan
Sunil Kochhar
Serge Andre Dominique Rezzi
Francoise-Pierre Martin
Emma Pere-Trepat
Sebastiano Collino
Vera Francia Arce
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of IN2012DN02624A publication Critical patent/IN2012DN02624A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/121Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/40Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06Anabolic agents
IN2624DEN2012 2009-10-09 2010-10-08 IN2012DN02624A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27863309P 2009-10-09 2009-10-09
PCT/US2010/002722 WO2011043827A1 (en) 2009-10-09 2010-10-08 Methods for preventing or treating sarcopenia and muscle atrophy in animals

Publications (1)

Publication Number Publication Date
IN2012DN02624A true IN2012DN02624A (es) 2015-05-22

Family

ID=43857050

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2624DEN2012 IN2012DN02624A (es) 2009-10-09 2010-10-08

Country Status (12)

Country Link
US (1) US9301941B2 (es)
EP (1) EP2485740B1 (es)
JP (1) JP6122638B2 (es)
CN (1) CN102573857A (es)
AU (1) AU2010303872B2 (es)
BR (1) BR112012008238A2 (es)
CA (1) CA2776950C (es)
ES (1) ES2688447T3 (es)
IN (1) IN2012DN02624A (es)
MX (1) MX2012004118A (es)
RU (1) RU2558534C2 (es)
WO (1) WO2011043827A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11090313B2 (en) 2010-05-20 2021-08-17 University Of Iowa Research Foundation Methods for inhibiting muscle atrophy
EP3520793B1 (en) 2011-06-06 2023-03-29 University of Iowa Research Foundation Substances and compostions for use in methods of inhibiting muscle atrophy
US9913823B2 (en) * 2011-10-18 2018-03-13 Amorepacific Corporation SIRT 1 activator including syringaresinol
MY194893A (en) * 2014-04-28 2022-12-22 Suntory Holdings Ltd Muscle atrophy inhibitor containing quercetin glycoside
CA2975217C (en) 2015-02-13 2023-08-15 Mars, Incorporated Pet food feeding system
KR20170002846A (ko) 2015-06-30 2017-01-09 (주)아모레퍼시픽 콩잎 추출물을 유효성분으로 함유하는 근질환 억제 및 예방용 조성물
GB201522304D0 (en) 2015-12-17 2016-02-03 Mars Inc Food product for reducing muscle breakdown
CN108635571B (zh) * 2018-07-19 2021-10-22 西安交通大学医学院第一附属医院 鸢尾素(irisin)在制备预防及治疗重症急性胰腺炎药物中的应用
EP4039329A4 (en) * 2019-10-04 2023-08-02 Suntory Holdings Limited COMPOSITION FOR SUPPRESSING LOSS OF MUSCLE MASS, PREVENTING LOSS INSIDE, MAINTAINING, RECOVERING OR ENHANCING ITS INSIDE
KR102623198B1 (ko) * 2020-02-26 2024-01-10 한국 한의학 연구원 돌콩 추출물을 유효성분으로 함유하는 근력강화, 근육증강, 근육분화, 근육재생 또는 근감소의 예방, 개선 또는 치료용 조성물
RU2756154C1 (ru) * 2020-11-13 2021-09-28 Митхат Зульфугар-Оглы Гасанов Способ диагностики саркопении у пациентов с хронической болезнью почек 5д стадии, получающих лечение программным гемодиализом
WO2023140407A1 (ko) * 2022-01-21 2023-07-27 경상국립대학교병원 쿠메스트롤을 포함하는 근감소증 예방 또는 치료용 약학 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU166380B (es) 1973-07-09 1975-03-28
US6887499B2 (en) * 2000-05-22 2005-05-03 Enitan A. Bababunmi Formulation and method for treating skeletal muscle degeneration caused by malnutrition and disease
EP1192943A3 (en) * 2000-09-28 2002-11-27 Pfizer Products Inc. Use of growth hormone secretagogues in conjunction with physical exercise
AUPR846401A0 (en) * 2001-10-25 2001-11-15 Novogen Research Pty Ltd 6-Hydroxy isoflavones, derivatives and medicaments involving same
JP5384777B2 (ja) 2001-12-18 2014-01-08 有限会社大長企画 強筋肉剤、抗炎症剤
WO2005007676A2 (en) 2003-07-10 2005-01-27 Rajadhyaksha V J Glycopeptides for the treatment of als and other metabolic and autoimmune disorders
JP2007519743A (ja) 2004-01-29 2007-07-19 エリクシアー ファーマシューティカルズ, インコーポレイテッド ウイルス障害の処置
CA2559974C (en) * 2004-03-17 2012-08-14 Nestec S.A. Compositions and methods for reducing or preventing obesity
JP2009537582A (ja) 2006-05-24 2009-10-29 ディーエスエム アイピー アセッツ ビー.ブイ. 有機化合物の新しい用途
JP5345534B2 (ja) * 2006-08-24 2013-11-20 ユニバーシティ オブ テネシー リサーチ ファウンデーション 置換アシルアニリドおよびそれらの使用方法

Also Published As

Publication number Publication date
EP2485740A1 (en) 2012-08-15
AU2010303872A1 (en) 2012-04-19
CA2776950A1 (en) 2011-04-14
ES2688447T3 (es) 2018-11-02
JP2013507361A (ja) 2013-03-04
MX2012004118A (es) 2012-05-08
RU2558534C2 (ru) 2015-08-10
WO2011043827A1 (en) 2011-04-14
US20120238515A1 (en) 2012-09-20
JP6122638B2 (ja) 2017-04-26
EP2485740B1 (en) 2018-08-29
CN102573857A (zh) 2012-07-11
EP2485740A4 (en) 2013-04-03
CA2776950C (en) 2023-11-21
RU2012118686A (ru) 2013-11-20
AU2010303872B2 (en) 2016-06-23
BR112012008238A2 (pt) 2017-06-06
US9301941B2 (en) 2016-04-05

Similar Documents

Publication Publication Date Title
IN2012DN02624A (es)
MX2011009539A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso.
IN2012DN00624A (es)
MX2010004219A (es) Agentes de enlace de cd19 y usos de los mismos.
IN2012DN00572A (es)
MX343135B (es) Compuestos de tipo fumagilol y métodos de realización y uso de los mismos.
WO2009129246A3 (en) Compositions and methods for preparing and using same
MX2009009761A (es) Composiciones y estuches para tratamiento de la influenza.
IN2012DN02735A (es)
IN2012DN02730A (es)
IN2012DN00754A (es)
MX2010003013A (es) Inhibicion de angiogenesis.
IN2012DN00971A (es)
MX2009010960A (es) Compuestos heterociclicos y sus metodos de uso.
TN2011000482A1 (en) Organic compounds and their uses
MY153948A (en) Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
TNSN08400A1 (en) Organic compounds and their uses
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
IN2012DN02471A (es)
MX2009005725A (es) Metodos y composiciones para tratamiento y monitoreo de tratamiento de trastornos asociados con il-13.
MX368459B (es) Nuevas composiciones para prevenir y/o tratar trastornos degenerativos del sistema nervioso central.
MX2013011996A (es) Metodos para regular la expresion de genes de sirtuina.
MY164998A (en) Isoquinolinone derivatives as nk3 antagonists
EA201200428A1 (ru) Композиция и способ для лечения ожирения
IN2012DN03187A (es)